Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Interventional Radiology(Electronic Edition) ›› 2019, Vol. 07 ›› Issue (03): 206-210. doi: 10.3877/cma.j.issn.2095-5782.2019.03.007

Special Issue:

• Monographi Study·Tumor Intervention • Previous Articles     Next Articles

The analysis of epidemiological characteristics of primary liver cancer in our hospital from 2001 to 2017

Sangwangmu Ge1, Zhongfei Chang2,(), Yalu Du1, Yunqi Liu1, Yaxin Liu1, Modi Li1   

  1. 1. Capital Medical University Class of 2015 Five-year Clinical Medical (Directional) Major, Beijing 100043, China
    2. Department of TCM, Beijing Shijianshan Hospital, Shijingshan Teaching Hospital of Capital Medical University, Beijing 100043, China
  • Received:2019-06-03 Online:2019-08-01 Published:2019-08-01
  • Contact: Zhongfei Chang
  • About author:
    Corresponding author: Chang Zhongfei, Email:

Abstract:

Objective:

To analyze the etiology and epidemiology of primary liver cancer in our hospital.

Methods:

358 patients hospitalized from January 2001 to December 2017 were investigated and analyzed. According to the treatment methods, the patients were divided into the palliative treatment group (148 cases) and the comprehensive treatment group (210 cases) .

Results:

Among the 358 patients, 298 were male (83.24%) and 60 were female (16.8%) . The patients were 23-92 (64.9±10.3) years old. There were 293 cases (81.84%) of hepatitis B virus (HBV) infection, 23 cases (6.42%) of hepatitis C virus (HCV) infection, 29 cases (8.10%) of alcoholic cirrhosis, 13 cases (3.63%) of non-alcoholic steatohepatitis, and 66 cases (18.44%) of family history of liver cancer. There was no significant difference in age, sex, tumor number and serum AFP level between the two groups (P>0.05) . However, there were statistically significant differences in tumor size, Child grade, ECOG score, presence or absence of portal vein cancer thrombus, and BCLC staging (P<0.05) . The 1-year, 2-year, and 3-year survival rates in the palliative care group were 60.1%, 14.2%, and 4.1%, respectively. Comprehensive treatment group of patients with 1, 2, 3 year survival rates were 77.1%, 42.4% and 33.3% respectively, the difference is statistically significant (P<0.001) .

Conclusions:

This study for clinical prevention and control to provide evidence for primary liver cancer, provide a reference for the treatment of liver cancer model, comprehensive treatment methods to improve the patients quality of life, improve the survival time of treatment.

Key words: Hepatocellular carcinoma, Epidemiology, Pathogeny, Hepatitis B virus, Hepatitis C virus

京ICP 备07035254号-20
Copyright © Chinese Journal of Interventional Radiology(Electronic Edition), All Rights Reserved.
Tel: 0756-2528259 E-mail: zhjrfsx@163.com
Powered by Beijing Magtech Co. Ltd